State Ledger
Company profile

Royalty Pharma plc CIK 1802768

Ticker
RPRX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10022
Fiscal year end
2025 (FY)
Market Data
Close
$57.80
Change
+$0.90
Change %
1.58%
Volume
191,105

RPRX · trading date Oct 12, 2026 · previous close $56.90 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$2.38B
Net income
$770.95M
Total assets
$19.62B
Total liabilities
$9.91B
Stockholders' equity
$9.71B
Cash & equivalents
$618.70M
Operating income
$1.56B
Operating cash flow
$2.49B
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-02-11. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
65.6%
Net margin
32.4%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
50.5%
Equity / assets
49.5%
CapEx / revenue
—
Operating cash flow / net income
3.23×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $2.38B $770.95M $19.62B $9.91B $9.71B
2024 $2.26B $858.98M $18.22B $7.88B $10.34B
2023 $2.35B $1.13B $16.38B $6.30B $10.08B
2022 $2.24B $42.83M $16.81B $7.29B $9.53B
2021 $2.29B $619.73M $17.52B $7.27B $10.25B
Company Details
SIC code
2834
State of incorporation
X0
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-19
Financials filed via
Form 10-K
filed 2026-02-11

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10022
110 EAST 59TH STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:45 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies